Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C524063 |
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one |
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one inhibits the reaction [[F3 protein co-treated with F7 protein] results in increased expression of BCL2 protein] | affects cotreatment|decreases reaction|increases expression | 18325115
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of F7 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of F7 mRNA | affects expression | 16483693
|
C010680 |
antibiotic G 418 |
antibiotic G 418 results in increased expression of and results in increased activity of F7 protein | increases activity|increases expression | 16706976
|
C034528 |
CycloProvera |
CycloProvera results in decreased expression of F7 protein | decreases expression | 14561536
|
C023635 |
dienogest |
[Ethinyl Estradiol co-treated with dienogest] results in increased expression of F7 protein | affects cotreatment|increases expression | 15288212
|
D004317 |
Doxorubicin |
[[F3 protein co-treated with F7 protein] results in increased expression of BCL2 protein] which results in decreased susceptibility to Doxorubicin | affects cotreatment|decreases response to substance|increases expression | 18325115
|
C418365 |
estradiol, norethindrone drug combination |
estradiol, norethindrone drug combination results in decreased expression of F7 protein | decreases expression | 14561536
|
C454300 |
estradiol valerate-dienogest |
[Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in increased expression of F7 protein | affects cotreatment|increases expression | 15288212
|
D004966 |
Estrogens, Conjugated (USP) |
Estrogens, Conjugated (USP) results in increased expression of F7 protein | increases expression | 15850603
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol binds to Norethindrone] which results in increased expression of F7 protein | affects binding|increases expression | 14561536
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with dienogest] results in increased expression of F7 protein | affects cotreatment|increases expression | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with estradiol valerate-dienogest] results in increased expression of F7 protein | affects cotreatment|increases expression | 15288212
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of F7 protein | affects cotreatment|increases expression | 12616980 12618251
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of F7 protein | affects cotreatment|decreases expression | 15157790
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of F7 protein | affects cotreatment|increases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of F7 protein | affects cotreatment|increases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
F7 gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of F7 protein] | affects cotreatment|affects reaction|increases expression | 12616980
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of F7 mRNA | affects expression | 17555576
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in increased expression of F7 protein | increases expression | 12616980 12618251
|
C442659 |
ethinyl estradiol-desogestrel combination |
F7 gene polymorphism affects the reaction [ethinyl estradiol-desogestrel combination results in increased expression of F7 protein] | affects reaction|increases expression | 12616980
|
C056933 |
fumonisin B1 |
fumonisin B1 results in decreased expression of F7 mRNA | decreases expression | 16221962
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of F7 protein | affects cotreatment|increases expression | 12616980 12618251
|
C033273 |
Gestodene |
F7 gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of F7 protein] | affects cotreatment|affects reaction|increases expression | 12616980
|
D009640 |
Norethindrone |
[Ethinyl Estradiol binds to Norethindrone] which results in increased expression of F7 protein | affects binding|increases expression | 14561536
|
C017576 |
norgestimate |
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of F7 protein | affects cotreatment|increases expression | 12618251
|
D016912 |
Levonorgestrel |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of F7 protein | affects cotreatment|decreases expression | 15157790
|
D016912 |
Levonorgestrel |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of F7 protein | affects cotreatment|increases expression | 12618251
|
C516519 |
NuvaRing |
NuvaRing results in increased expression of F7 protein | increases expression | 15157790
|
D010126 |
Ozone |
TTPA protein affects the reaction [Ozone results in increased expression of F7 mRNA] | affects reaction|increases expression | 19555225
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of F7 mRNA | decreases expression | 18467677
|
C023036 |
perfluorooctanoic acid |
PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of F7 mRNA] | decreases expression|increases reaction | 18467677
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of F7 mRNA | decreases expression | 16221962 18467677 20059764
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of F7 mRNA] | decreases expression|increases reaction | 20059764 18467677
|
D012906 |
Smoke |
Smoke results in increased secretion of F7 protein | increases secretion | 17041012
|
C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of F7 mRNA | decreases expression | 16882884
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of F7 mRNA | affects expression | 17555576
|
D014859 |
Warfarin |
F7 gene polymorphism affects the susceptibility to Warfarin | affects response to substance | 14656880
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.35 | 14745880 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.37 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
11.68 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
norgestimate |
11.68 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.94 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.23 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.23 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.29 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.36 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.40 | 15513908 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.65 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.28 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.55 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.51 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.58 | 17854713 16373670 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
2.97 | 19483382 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.51 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.64 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.33 | 15994142 16935488 18382427 16595493 17983394 15939500 16322301 15634643 17426702 16264153 15993339 18695136 16826403 19526202 17369602 15136595 15692762 18628466 11325840 18234424 15567936 16096432 16115903 15668708 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.33 | 11161223 17893378 19155303 19288272 19011961 19221464 18629630 19189210 18351453 20544844 20135344 15565566 16202921 19189212 18855134 18815881 19084267 20859285 15668708 19200415 19115204 19244106 16818667 19103187 17049068 21152245 17242785 18984771 16873071 19066611 20390343 17440819 20065188 19410462 20005174 19289846 19487384 18997820 19142967 19059307 18821012 18425577 17261762 21138602 16273361 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.53 | 17626835 18315731 19059883 15516495 16777450 18417511 14754758 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.55 | 16183385 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.62 | 16051944 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.32 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.40 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.40 | 18059187 17876044 16023760 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.40 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.07 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.58 | 6189445 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.45 | 17572228 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.41 | 16364871 17007740 17351982 17928571 18627295 16455267 17329180 16612575 17131338 17519947 15505089 17974986 16109756 16952015 16269455 15476868 16731534 17308081 15792986 17382496 16651473 17924179 16278810 16242529 15811867 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.88 | 17334414 16243910 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.47 | 10977129 |
MESH:D002543 |
Cerebral Hemorrhage |
|
Warfarin |
5.66 | 11061249 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.80 | 17110522 16105132 11677210 17681005 15861022 16919318 17333356 |
MESH:D002779 |
Cholestasis |
|
Levonorgestrel |
12.80 | 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.80 | 19176532 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D023903 |
Coronary Restenosis |
|
Warfarin |
5.49 | 12872399 |
OMIM:122700 |
COUMARIN RESISTANCE |
|
Warfarin |
5.64 | 20497562 20579077 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
2.71 | 10525206 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.17 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.34 | 18249437 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Warfarin |
4.00 | 18772604 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.92 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Warfarin |
8.92 | 12644472 |
MESH:D003875 |
Drug Eruptions |
|
Warfarin |
5.79 | 14723717 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.60 | 12540782 15968718 10915739 16781746 12153990 11421492 14550746 14725611 11287661 17522070 17906064 16177239 18071297 19085960 19923254 12958197 12594235 12705907 16081117 19416960 16393943 14986274 10663392 11461765 19164858 16227642 18713872 19739265 11743745 11834606 16485898 11529661 15619225 16109766 11739529 19370779 10774834 17562736 12392966 2444490 19420014 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
8.60 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
8.60 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
8.60 | 18186108 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.91 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.53 | 18602426 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
6.41 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.41 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.33 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.33 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.15 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.15 | 19155303 16202921 20544844 17893378 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.96 | 18037988 |
MESH:D005168 |
Factor VII Deficiency |
marker/mechanism |
|
| |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.04 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.04 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
12.04 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.12 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.34 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
10.80 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
10.80 | 19069698 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.48 | 16983495 |
MESH:D006471 |
Gastrointestinal Hemorrhage |
|
Warfarin |
6.52 | 11794436 |
MESH:D005776 |
Gaucher Disease |
|
Warfarin |
5.77 | 12359135 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.23 | 17150277 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
4.90 | 19446573 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.40 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.35 | 18006777 16244372 17875725 16330681 16879835 16144979 14766674 16707910 16495754 18674790 17888722 16244371 12587719 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.66 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.66 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.73 | 15692506 |
MESH:D006406 |
Hematoma |
|
Warfarin |
6.52 | 17493413 |
MESH:D006470 |
Hemorrhage |
|
Warfarin |
5.28 | 18429757 |
MESH:D006474 |
Hemorrhagic Disorders |
marker/mechanism |
|
| 16706976 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
13.55 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
13.55 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.55 | 16221962 19772884 19176532 18467677 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.25 | 18501091 17606976 15147373 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.36 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.36 | 12083418 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.02 | 20558911 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Warfarin |
4.67 | 12359135 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.62 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.28 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.36 | 17937319 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
5.01 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.01 | 19457130 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.51 | 16306350 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.70 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
5.70 | 15699352 16775033 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.98 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
2.89 | 18625569 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.96 | 16085563 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.04 | 8812269 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.02 | 17567588 15342952 |
MESH:D054068 |
Livedo Reticularis |
|
Warfarin |
6.52 | 18280355 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.38 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.38 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.38 | 18564211 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.59 | 19784758 19460945 16611625 19014921 12587719 12969438 16610002 11587558 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.07 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
7.07 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.07 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.07 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
2.90 | 17085340 16842330 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.25 | 8266340 19066396 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.66 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.79 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
4.79 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Smoke |
4.79 | 11091918 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.79 | 18625569 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.33 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.63 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.38 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.57 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
5.74 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
5.74 | 19196723 11731420 16827153 14580682 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.35 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.30 | 16827129 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.30 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.99 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.38 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.98 | 17638057 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.91 | 10496685 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.32 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.60 | 17415656 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.32 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.68 | 18186108 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.45 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.45 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.80 | 16411023 |
MESH:D009336 |
Necrosis |
|
Warfarin |
5.35 | 14723717 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
5.62 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.62 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.45 | 19410462 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.86 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.81 | 19196722 19189210 19200415 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.58 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.84 | 16889571 15640375 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
3.83 | 18186108 19446573 10525206 11749123 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.17 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.72 | 18514411 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.76 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.77 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Levonorgestrel |
4.55 | 12665316 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.96 | 15930896 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.24 | 16870215 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.51 | 11578682 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.94 | 16369182 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.96 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.96 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.20 | 18381685 18929643 18007984 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
ethinyl estradiol-desogestrel combination |
5.43 | 17105841 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
4.20 | 17132714 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.41 | 16888761 15897917 16868541 16729912 15749863 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.41 | 15067354 |
MESH:D020151 |
Protein C Deficiency |
|
Warfarin |
6.16 | 18376272 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
9.36 | 15861022 16919318 |
MESH:D011537 |
Pruritus |
|
Levonorgestrel |
9.36 | 15861022 |
MESH:D011655 |
Pulmonary Embolism |
|
Warfarin |
6.16 | 19300499 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.03 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.29 | 19058328 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.82 | 16767912 18313854 17203757 15675481 17710206 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.06 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.60 | 17846226 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Warfarin |
5.68 | 12269725 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
2.87 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.38 | 16767912 15625365 17203757 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.92 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.92 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.85 | 19457130 |
MESH:D020521 |
Stroke |
|
Warfarin |
4.83 | 19300499 |
MESH:D013923 |
Thromboembolism |
|
Warfarin |
5.97 | 16960144 18698879 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
24.63 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
ethinyl estradiol-desogestrel combination |
24.63 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Gestodene |
24.63 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Warfarin |
24.63 | 17493413 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
14.63 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Gestodene |
14.63 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Warfarin |
14.63 | 17245631 19300499 11518727 15720958 11307788 17672075 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.23 | 16010429 17909728 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
4.96 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
4.96 | 16712894 17572228 8653321 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.80 | 10982225 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.12 | 14692618 |
MESH:D014657 |
Vasculitis |
|
Warfarin |
5.68 | 20337814 |
MESH:D054556 |
Venous Thromboembolism |
|
Warfarin |
6.17 | 18776969 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
23.90 | 15869587 14671159 |
MESH:D020246 |
Venous Thrombosis |
|
ethinyl estradiol-desogestrel combination |
23.90 | 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Levonorgestrel |
23.90 | 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Warfarin |
23.90 | 15733061 14723717 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.03 | 17678736 17638931 17334414 16364871 |